# FDA Inspection 1082630 - Nationwide Children's Hospital IRB - March 11, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/nationwide-childrens-hospital-irb/0a620a48-96fd-4251-af1e-18e62368af3b
Source feed: FDA_Inspections

> FDA Inspection 1082630 for Nationwide Children's Hospital IRB on March 11, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082630
- Company Name: Nationwide Children's Hospital IRB
- Inspection Date: 2019-03-11
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1019123 - 2017-05-26](https://www.globalkeysolutions.net/records/fda_inspections/nationwide-childrens-hospital-irb/ba0484bf-e5f5-4f9e-96cd-9594f1cdf2a4)
- [FDA Inspection 815710 - 2013-01-25](https://www.globalkeysolutions.net/records/fda_inspections/nationwide-childrens-hospital-irb/0294a520-0dbc-4a05-96a2-e01169bc7637)
- [FDA Inspection 675658 - 2010-08-13](https://www.globalkeysolutions.net/records/fda_inspections/nationwide-childrens-hospital-irb/60ffc89a-7c55-4eae-b68e-bbbce0c1d9b0)

Company: https://www.globalkeysolutions.net/companies/nationwide-childrens-hospital-irb/c498e49d-6982-4fcb-8748-9057474b7da8

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d